| __timestamp | Vericel Corporation | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13774000 | 7751000 |
| Thursday, January 1, 2015 | 22479000 | 10251000 |
| Friday, January 1, 2016 | 27388000 | 9575000 |
| Sunday, January 1, 2017 | 35610000 | 10912000 |
| Monday, January 1, 2018 | 49007000 | 11049000 |
| Tuesday, January 1, 2019 | 61139000 | 11646000 |
| Wednesday, January 1, 2020 | 68836000 | 13265000 |
| Friday, January 1, 2021 | 97592000 | 25805000 |
| Saturday, January 1, 2022 | 106903000 | 35182000 |
| Sunday, January 1, 2023 | 120998000 | 94999000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, operational efficiency is paramount. Over the past decade, Vericel Corporation and Viridian Therapeutics, Inc. have demonstrated contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. Vericel's SG&A expenses have surged by nearly 780% from 2014 to 2023, reflecting its aggressive growth strategy. In contrast, Viridian's expenses have increased by approximately 1,125%, indicating a significant ramp-up in its operational activities.
This analysis underscores the dynamic nature of the biotech sector, where strategic investments in SG&A can drive substantial growth.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation
Selling, General, and Administrative Costs: Alnylam Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation
Dr. Reddy's Laboratories Limited and Vericel Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Vericel Corporation vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? ImmunityBio, Inc. or Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.